HEALTH
New Hope in Fighting Insulin Resistance
Fri Mar 28 2025
Insulin resistance is a tricky health issue. It happens when the body stops responding well to insulin. This can lead to high blood sugar levels and even diabetes. While changing habits can help, current medicines have their limits. This is where natural solutions come in.
Researchers have found two new compounds that might help. They are called 8-hydroxy-dihydroquercetin and dihydroquercetin-7-O-β-d-(4″-O-methyl)-glucoside. These are made from a plant compound called dihydroquercetin. The cool part is that they were created using a fungus called Beauveria bassiana. This fungus is known for its ability to change natural compounds in useful ways.
These new compounds were tested on liver cells. The results were promising. They showed that these compounds can reduce inflammation and stress in cells. This is important because inflammation and stress can make insulin resistance worse. By reducing these, the compounds help cells respond better to insulin.
The compounds also help in other ways. They boost the body's ability to store glucose as glycogen. They also reduce the production of glucose in the liver. This is good because it helps keep blood sugar levels in check. All of these effects are due to the compounds' ability to activate certain pathways in the body. These pathways are involved in how the body uses glucose.
This research is exciting because it shows that natural compounds can be modified to fight insulin resistance. It also shows that microbial fermentation can be a useful tool in creating these compounds. This could lead to new and better treatments for insulin resistance and diabetes.
However, it's important to remember that this is just one study. More research is needed to fully understand the effects of these compounds. But the results so far are promising. They give hope that natural solutions can play a big role in managing insulin resistance.
continue reading...
questions
How do the results of this study compare with other existing treatments for insulin resistance in terms of efficacy and safety?
What are the potential long-term effects of using H-DHQ and DHQ-MG in managing insulin resistance?
Can the findings from the HepG2 cell model be directly translated to human clinical outcomes?
actions
flag content